161 related articles for article (PubMed ID: 38658630)
1. MRI radiomics in head and neck cancer from reproducibility to combined approaches.
Corti A; Cavalieri S; Calareso G; Mattavelli D; Ravanelli M; Poli T; Licitra L; Corino VDA; Mainardi L
Sci Rep; 2024 Apr; 14(1):9451. PubMed ID: 38658630
[TBL] [Abstract][Full Text] [Related]
2. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
3. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
5. Radiomic biomarkers for head and neck squamous cell carcinoma.
Tanadini-Lang S; Balermpas P; Guckenberger M; Pavic M; Riesterer O; Vuong D; Bogowicz M
Strahlenther Onkol; 2020 Oct; 196(10):868-878. PubMed ID: 32495038
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
7. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
Philip MM; Welch A; McKiddie F; Nath M
Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
[TBL] [Abstract][Full Text] [Related]
9. Radiomics from dual-energy CT-derived iodine maps predict lymph node metastasis in head and neck squamous cell carcinoma.
Zhang W; Liu J; Jin W; Li R; Xie X; Zhao W; Xia S; Han D
Radiol Med; 2024 Feb; 129(2):252-267. PubMed ID: 38015363
[TBL] [Abstract][Full Text] [Related]
10. Does Dual-Energy Computed Tomography Material Decomposition Improve Radiomics Capability to Predict Survival in Head and Neck Squamous Cell Carcinoma Patients? A Preliminary Investigation.
Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Pinto Dos Santos D
J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):323-333. PubMed ID: 38013237
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Model Using Radiomics Features from an Apparent Diffusion Coefficient Map to Diagnose Local Tumor Recurrence in Patients Treated for Head and Neck Squamous Cell Carcinoma.
Kim M; Lee JH; Joo L; Jeong B; Kim S; Ham S; Yun J; Kim N; Chung SR; Choi YJ; Baek JH; Lee JY; Kim JH
Korean J Radiol; 2022 Nov; 23(11):1078-1088. PubMed ID: 36126954
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
Chen W; Lin G; Chen Y; Cheng F; Li X; Ding J; Zhong Y; Kong C; Chen M; Xia S; Lu C; Ji J
BMC Cancer; 2024 Apr; 24(1):418. PubMed ID: 38580939
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Application for Head and Neck Squamocellular Tumor: Systematic Review.
Messineo D; Massaro F; Izzo P; Milani A; Polimeni R; Iannella G; Marinozzi S; Consorti F; Cocuzza S; Maniaci A; Mucchino A; Nannarelli M; Greco A; Magliulo G; Salducci M; Pace A
Clin Ter; 2024; 175(2):153-160. PubMed ID: 38571474
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
[TBL] [Abstract][Full Text] [Related]
15. Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
Bogowicz M; Leijenaar RTH; Tanadini-Lang S; Riesterer O; Pruschy M; Studer G; Unkelbach J; Guckenberger M; Konukoglu E; Lambin P
Radiother Oncol; 2017 Dec; 125(3):385-391. PubMed ID: 29122358
[TBL] [Abstract][Full Text] [Related]
16. FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer.
Ulrich EJ; Menda Y; Boles Ponto LL; Anderson CM; Smith BJ; Sunderland JJ; Graham MM; Buatti JM; Beichel RR
Tomography; 2019 Mar; 5(1):161-169. PubMed ID: 30854454
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the MVCT-based radiomic features as prognostic factor in patients with head and neck squamous cell carcinoma.
Abe K; Kadoya N; Ito K; Tanaka S; Nakajima Y; Hashimoto S; Suda Y; Uno T; Jingu K
BMC Med Imaging; 2023 Aug; 23(1):102. PubMed ID: 37528392
[TBL] [Abstract][Full Text] [Related]
18. Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer.
Korte JC; Cardenas C; Hardcastle N; Kron T; Wang J; Bahig H; Elgohari B; Ger R; Court L; Fuller CD; Ng SP
Sci Rep; 2021 Sep; 11(1):17633. PubMed ID: 34480036
[TBL] [Abstract][Full Text] [Related]
19. Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
Gangil T; Sharan K; Rao BD; Palanisamy K; Chakrabarti B; Kadavigere R
PLoS One; 2022; 17(12):e0277168. PubMed ID: 36520945
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
